Underlying data failed quality checks; AI interpretation downgraded and shown for reference only.
Market Sentiment
The public offer was oversubscribed by 10.08 times, indicating moderate enthusiasm. The hit rate of 39.22% is relatively high, reflecting that the allocation was not excessively competitive. Reallocation from the international tranche suggests that institutional demand was softer, making more shares available to retail investors. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Tier Analysis
No tier distribution data was provided, making it impossible to analyze 甲尾/乙头 inefficiencies or broker fee dynamics. Investors should refer to the official allocation results for detailed tier-level statistics. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
Demographics
Demographic data for this IPO was not available in the provided dataset. Typically, Hong Kong IPO filings include breakdowns of applicant regions and identity types, but they were missing here. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)
About this page
This page shows Sunho Bio-B (02898) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.